Images List Premium Download Classic

Expression Vector

Expression Vector-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Bacterial resistant transgenic plants having dysfunctional t3ss proteins
Futuragene Israel Ltd.
September 14, 2017 - N°20170260542

A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative t3ss protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative t3ss protein mediates assembly of a dysfunctional needle complex.
Methionine lyase, encoding gene and biosynthetic method thereof
Hubei University Of Technology
September 14, 2017 - N°20170260518

Embodiment of the present invention discloses a kind of methionine lyase and its encoding gene and biosynthetic method. According to the present invention, the gene encoding methionine lyase as shown in seq id no. 1 is separated from the genome of c. Rosea. Embodiment of the present invention further provides an efficient biosynthetic method of methionine lyase, comprising: (1) cloning gene (shown ...
Antibody binding specifically to pre-s1 of hepatitis b virus and use of the antibody
Geneone Life Science, Inc.
September 14, 2017 - N°20170260258

Provided are: an antibody binding specifically to a surface antigen, pre-s1, of a hepatitis b virus (hbv); a polynucleotide coating the antibody; an expression vector comprising the polynucleotide; a transformation agent comprising the expression vector; and use of the antibody in treating or preventing hbv infection and in detecting an hbv.
Expression Vector Patent Pack
Download 166+ patent application PDFs
Expression Vector Patent Applications
Download 166+ Expression Vector-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Expression Vector-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Promoter and regulatory elements for improved expression of heterologous genes in host cells
Amgen Inc.
September 07, 2017 - N°20170253889

Disclosed are a recombinant expression vector and a host cell that contains the vector.
Antibodies against cd73
Bristol-myers Squibb Company
September 07, 2017 - N°20170253665

The present invention provides isolated monoclonal antibodies, particularly human antibodies, that bind to human cluster of differentiation 73 (cd73) with high affinity, and inhibit the activity of cd73, and optionally mediate antibody dependent cd73 internalization. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, ...
In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes
California Institute Of Technology
August 31, 2017 - N°20170247725

The present invention provides methods for catalyzing the conversion of an olefin to any compound containing one or more cyclopropane functional groups using heme enzymes. In certain aspects, the present invention provides a method for producing a cyclopropanation product comprising providing an olefinic substrate, a diazo reagent, and a heme enzyme; and admixing the components in a reaction for a ...
Expression Vector Patent Pack
Download 166+ patent application PDFs
Expression Vector Patent Applications
Download 166+ Expression Vector-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Expression Vector-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for prenylation of peptides and their use in over-production of farnesene and geranylgeranyl terpenes
University Of North Texas
August 24, 2017 - N°20170240926

Methods for concentrating biofuel precursors, including terpenes such as farnesyl and geranylgeranyl derivatives, are based on the prenylation of peptides in living organisms, such as plant or algae cells. Generally, an expression vector containing a gene encoding a small peptide with a preferred amino acid sequence is used to produce a transgenic organism. Expression of the gene in the cells ...
Production of recombinant expression vectors
Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
August 24, 2017 - N°20170240907

The present invention relates to a method for the production of recombinant expression vectors, a kit adapted to carrying out the method, a vector used in the context of the method, a cell containing such vector and the use of the vector.
Lysin agent and method of use for diagnostic testing
The Government Of The United States Of America, As Represented By The Secretary Of Homeland Securit
August 24, 2017 - N°20170240876

Disclosed herein are the identification, cloning, and optimizing the lytic activity of one or more novel bacillus lysin proteins, a method of selecting a lysin agent for use in molecular diagnostic testing that includes analyzing genome databases for bacillus anthracis and near neighbors, selecting candidate genes encoding potential lytic enzymes based on conserved amino acid motifs as determined in peptidoglycan ...
Cell culture media composition and methods of producing thereof
Neuclone Biologics Pty Ltd
August 17, 2017 - N°20170233695

A serum free cell culture media, wherein the media is adapted to be conditioned by culturing a first set of eukaryotic cells in the media, wherein the first set of eukaryotic cells use an expression vector to excrete levels of desired complex proteins into the media; wherein said desired complex proteins include human growth hormone (hgh), growth hormone-like growth factors, ...
Insecticidal proteins and methods for their use
E. I. Du Pont De Nemours And Company
August 17, 2017 - N°20170233440

Compositions and methods for controlling pests are provided. The methods involve transforming organisms with a nucleic acid sequence encoding an insecticidal protein. In particular, the nucleic acid sequences are useful for preparing plants and microorganisms that possess insecticidal activity. Thus, transformed bacteria, plants, plant cells, plant tissues and seeds are provided. Compositions are insecticidal nucleic acids and proteins of bacterial ...
Genetically recombinant saccharomyces cerevisiae for degrading kitchen waste
Guangdong Qizhi Biotechnology Co., Ltd
August 10, 2017 - N°20170226539

Disclosed is a genetically recombinant saccharomyces cerevisiae useful for degrading and utilizing kitchen wastes. Genes encoding α-amylase(amy), glucoamylase (ga) and acid protease (ap) were introduced into the genetically recombinant saccharomyces cerevisiae using a saccharomyces cerevisiae multi-gene co-expression vector and successfully expressed and secreted. The saccharomyces cerevisiae so obtained are capable of secreting amylases and protease to degrade ...
Plants with enhanced size and growth rate
Mendel Biotechnology, Inc.
August 10, 2017 - N°20170226528

Polynucleotides and polypeptides incorporated into expression vectors have been introduced into plants and were ectopically expressed. The polypeptides of the invention regulate transcription in these plants and have been shown to confer at least one regulatory activity that results in increased size, biomass, growth rate, and/or yield as compared to a control plant.
Expression Vector Patent Pack
Download 166+ patent application PDFs
Expression Vector Patent Applications
Download 166+ Expression Vector-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Expression Vector-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and materials for obtaining hepatocyte lineage cells
National University Corporation Chiba University
August 03, 2017 - N°20170218394

Methods of producing hepatocyte lineage cells are provided. The method can include transfecting a cell with one or more expression vectors. For example, a cell can be transfected with a first expression vector containing a first gene that encodes ccaat/enhancer binding protein alpha (cebpa), a second expression vector containing a second gene that encodes ccaat/enhancer binding protein beta (...
Transcription regulators for improving plant performance
Mendel Biotechnology, Inc.
August 03, 2017 - N°20170218383

Transcription factor polynucleotides and polypeptides incorporated into nucleic acid constructs, including expression vectors, have been introduced into plants and were ectopically expressed. Transgenic plants transformed with many of these constructs have been shown to have increased tolerance to an abiotic stress (in some cases, to more than one abiotic stress), increased growth, and/or increased biomass. The abiotic stress may ...
Secretion signal peptide, and protein secretory production and cell surface display using said secretion signal ...
National University Corporation Kobe University
August 03, 2017 - N°20170218382

An expression vector is disclosed which contains a promoter dna; a dna encoding a peptide having a defined amino acid sequence and having secretion signal activity; and a dna encoding an intended protein or a cloning site for insertion of the dna encoding an intended protein. An expression vector is also disclosed which contains a promoter dna; a dna encoding ...
Anti-epidermal growth factor receptor (egfr) antibodies
Henlius Biotech Co., Ltd.
August 03, 2017 - N°20170218073

Provided are anti-epidermal growth factor receptor (egfr) antibodies, aglycosylated cdr-h2 anti-egfr antibodies, and antigen binding fragments thereof. Also provided are isolated nucleic acid molecules that encode the anti-egfr antibodies or antigen binding fragments thereof, related expression vectors, and host cells. Provided are methods of making anti-epidermal growth factor receptor (egfr) antibodies, aglycosylated cdr-h2 anti-egfr antibodies, and antigen binding fragments thereof. ...
Antibody gene expression-secretion system
Shinshu University
August 03, 2017 - N°20170218072

It is an object of the present invention to provide signal sequence information capable of secreting an antibody to the outside of cells in generation of the antibody by microorganisms of genus bifidobacterium, and an antibody expression vector capable of secreting an antibody to the outside of cells by utilizing the signal sequence information. As a means for achieving the ...
T cell receptors
Adaptimmune Limited
August 03, 2017 - N°20170218043

The present invention relates to t cell receptors (tcrs) which bind the hla-a*02 restricted peptide glydgmehl (seq id no: 1) derived from the mage-a10 protein. The tcrs of the invention demonstrate excellent specificity profiles for this mage epitope. Also provided are nucleic acids encoding the tcrs, cells engineered to present the tcrs, cells harbouring expression vectors encoding the tcrs and pharmaceutical ...
Intrathecal delivery of recombinant adeno-associated virus 9
Ohio State Innovation Foundation
August 03, 2017 - N°20170216458

The present invention relates to adeno-associated virus type 9 methods and materials useful for intrathecal delivery of polynucleotides. Use of the methods and materials is indicated, for example, for treatment of lower motor neuron diseases such as sma and als as well as pompe disease and lysosomal storage disorders. It is disclosed that administration of a non-ionic, low-osmolar contrast agent, together ...
Pseudomonas exotoxin a with less immunogenic b cell epitopes
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv
August 03, 2017 - N°20170216398

The invention provides a pseudomonas exotoxin a (pe) comprising an amino acid sequence having a substitution of one or more of amino acid residues e420, d463, y481, l516, r563, d581, d589, and k606, wherein the amino acid residues are defined by reference to seq id no: 1. The invention further provides related chimeric molecules, as well as related nucleic acids, recombinant ...
Loading